HBM HEALTHCARE INVESTMENTS AG Valuation HBM Healthcare Investments AG
Equities
HBMN
CH0012627250
Investment Management & Fund Operators
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 180.20 CHF | -0.44% |
|
-0.77% | +2.39% |
| Jan. 05 | HBM Healthcare Investments Reports Rise in FY25 Nine-month NAV | MT |
| Dec. 19 | HBM Healthcare Investments' Sai Life Sciences Completes India IPO | MT |
Company Valuation: HBM Healthcare Investments AG
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,320 | 2,313 | 1,920 | 1,489 | 1,338 | 1,233 | - | - |
| Change | - | 75.24% | -16.99% | -22.46% | -10.13% | -7.86% | - | - |
| Enterprise Value (EV) 1 | 1,320 | 2,409 | 2,064 | 1,632 | 1,427 | 1,116 | 1,107 | 1,094 |
| Change | - | 82.53% | -14.35% | -20.91% | -12.56% | -21.82% | -0.81% | -1.17% |
| P/E ratio | 7.24x | 3.06x | -24.6x | -10.2x | -2,766x | 25x | 11.8x | 11.6x |
| PBR | 1.01x | 1.08x | 0.97x | 0.84x | 0.78x | 0.74x | 0.72x | 0.69x |
| PEG | - | 0x | 0x | -0.1x | 27.8x | -0x | 0x | 5.72x |
| Capitalization / Revenue | - | - | -51.2x | -12.8x | 56.2x | 16x | 9.32x | 9.17x |
| EV / Revenue | - | - | -55x | -14x | 60x | 14.5x | 8.37x | 8.14x |
| EV / EBITDA | 7.13x | 3.18x | -27.4x | -11.2x | -554x | 21.6x | 10.3x | 10x |
| EV / EBIT | 7.13x | 3.18x | -27.4x | -11.2x | -554x | 21.6x | 10.3x | 10x |
| EV / FCF | -20.6x | 43.2x | -34.3x | 18.3x | 15.4x | 17.2x | 17.1x | 15.6x |
| FCF Yield | -4.86% | 2.31% | -2.92% | 5.46% | 6.51% | 5.82% | 5.86% | 6.39% |
| Dividend per Share 2 | 7.7 | 12.5 | 9.7 | 7.5 | 7.5 | 7.19 | 7.92 | 7.92 |
| Rate of return | 4.05% | 3.76% | 3.51% | 3.5% | 3.87% | 3.97% | 4.38% | 4.38% |
| EPS 2 | 26.26 | 108.7 | -11.22 | -20.98 | -0.07 | 7.24 | 15.29 | 15.6 |
| Distribution rate | 29.3% | 11.5% | -86.5% | -35.7% | -10,714% | 99.3% | 51.8% | 50.8% |
| Net sales 1 | - | - | -37.5 | -116.5 | 23.79 | 76.9 | 132.3 | 134.4 |
| EBITDA 1 | 185.1 | 758.7 | -75.31 | -146.1 | -2.574 | 51.7 | 107.1 | 109.3 |
| EBIT 1 | 185.1 | 758.7 | -75.31 | -146.1 | -2.574 | 51.7 | 107.1 | 109.3 |
| Net income 1 | 183 | 756.3 | -78.03 | -145.3 | -0.487 | 51.7 | 107.1 | 109.3 |
| Net Debt 1 | - | 96.21 | 143.5 | 143.5 | 89.16 | -117 | -126 | -139 |
| Reference price 2 | 190.00 | 332.50 | 276.00 | 214.00 | 193.60 | 181.00 | 181.00 | 181.00 |
| Nbr of stocks (in thousands) | 6,947 | 6,957 | 6,957 | 6,957 | 6,911 | 6,811 | - | - |
| Announcement Date | 5/8/20 | 5/27/21 | 5/18/22 | 5/26/23 | 5/8/24 | - | - | - |
1CHF in Million2CHF
Estimates
P/E ratio, Detailed evolution
| P/E ratio (Y) | EV / Sales | EV / EBITDA | Yield (Y) | Capi. ($) | ||
|---|---|---|---|---|---|---|
| 25x | 14.51x | 21.58x | +3.97% | 1.34B | ||
| 18.32x | 14.94x | 20.46x | +1.18% | 5.1B | ||
| 11.3x | - | - | +8.06% | 3.18B | ||
| -144.94x | 15.13x | 28.1x | -.--% | 619M | ||
| 12.66x | - | - | +12.64% | 590M | ||
| Average | -15.53x | 14.86x | 23.38x | +5.17% | 2.17B | |
| Weighted average by Cap. | 7.45x | 14.87x | 21.34x | +4.10% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- HBMN Stock
- Valuation HBM Healthcare Investments AG